Evidence
3 records3 recordsBest grade:High
The evidence for Lactobacillus crispatus is moderate to high, particularly in preventing bacterial vaginosis recurrence and aiding in microbiome restoration. However, the overall research is limited, and more studies are needed to confirm its efficacy in broader contexts.
Recurrence of bacterial vaginosisWomen aged 18 to 45 with a history of bacterial vaginosis · RCTHigh
Recurrence of bacterial vaginosis
Women aged 18 to 45 with a history of bacterial vaginosis · RCT
Lactobacillus crispatus CTV-05 significantly reduced the recurrence of bacterial vaginosis compared to placebo.
Dose: —Duration: 11 weeksForm: Lactin-V
Vaginal microbiome restorationWomen aged 18 to 45 post-metronidazole treatment for bacterial vaginosis · RCTModerate
Vaginal microbiome restoration
Women aged 18 to 45 post-metronidazole treatment for bacterial vaginosis · RCT
Lactobacillus crispatus CTV-05 was detected in 79% of participants, indicating successful colonization and microbiome restoration.
Dose: —Duration: 24 weeksForm: Lactin-V
Prevention of urinary tract infectionsWomen with a history of bacterial vaginosis · Systematic reviewLow
Prevention of urinary tract infections
Women with a history of bacterial vaginosis · Systematic review
Lactobacillus crispatus suppositories may help reduce the incidence of urinary tract infections.
Dose: —Form: Vaginal suppository
Stacks containing Lactobacillus crispatus
Explore all →No public stacks include this supplement yet.
Community Insights
Forms & usage▾
How to take it
Take as directed, typically in capsule or suppository form, preferably at bedtime.
Vaginal suppository
Direct application to the vaginal area for targeted microbiome support.
Oral capsule
Systemic probiotic support, though less direct for vaginal health.
My notes▾
Sign in to keep a private note on Lactobacillus crispatus.